I lead Haystack Medical, where we are translating advanced microengineering into breakthrough clinical solutions for hearing loss and diagnostics.
Haystack Medical received a $2.4 million STTR grant from NIDCD in September 2026.
Starting first-in-human (FIH) clinical trials at Columbia NYP in NYC, with the IRB protocol accepted.
Leveraging proprietary 2PTE-fabricated metallic microneedles to solve the "access challenge" of the Round Window Membrane.
If you are an investor or clinical partner interested in the future of otology, I’d love to connect.
aykut@haystackmedical.com